[{"address1": "890 Winter Street", "address2": "Suite 200", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 208 2466", "website": "https://upstreambio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. Its product candidate includes verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, as well as in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. E. Rand Sutherland M.D., M.P.H., MPH", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 869154, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael Paul Gray CPA, MBA", "age": 53, "title": "CFO & COO", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 607200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Allison C. Ambrose J.D.", "age": 39, "title": "Senior VP, General Counsel & Secretary", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 59792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Price M.S., P.M.P.", "age": 55, "title": "Chief Technology Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Fiering", "title": "Senior Vice President of People & Culture", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam  Houghton M.B.A., Ph.D.", "age": 53, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Aaron  Deykin M.D.", "age": 57, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 736700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mersedeh  Miraliakbari Pharm.D.", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Fang  Xie Ph.D.", "title": "VP & Head of Biometrics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sumathi  Sivapalasingam M.D.", "title": "VP & Head of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.98, "open": 10.92, "dayLow": 10.6, "dayHigh": 11.335, "regularMarketPreviousClose": 10.98, "regularMarketOpen": 10.92, "regularMarketDayLow": 10.6, "regularMarketDayHigh": 11.335, "payoutRatio": 0.0, "forwardPE": -4.670886, "volume": 127593, "regularMarketVolume": 127593, "averageVolume": 408555, "averageVolume10days": 722520, "averageDailyVolume10Day": 722520, "bid": 8.12, "ask": 14.02, "bidSize": 1, "askSize": 2, "marketCap": 595496256, "fiftyTwoWeekLow": 5.14, "fiftyTwoWeekHigh": 29.46, "priceToSalesTrailing12Months": 259.3625, "fiftyDayAverage": 9.8102, "twoHundredDayAverage": 13.46059, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 160974864, "profitMargins": 0.0, "floatShares": 31302018, "sharesOutstanding": 53793700, "sharesShort": 3610360, "sharesShortPriorMonth": 3746059, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0671, "heldPercentInsiders": 0.14840001, "heldPercentInstitutions": 0.8941, "shortRatio": 9.73, "shortPercentOfFloat": 0.121400006, "impliedSharesOutstanding": 53793700, "bookValue": 8.307, "priceToBook": 1.332611, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -89655000, "trailingEps": -1.67, "forwardEps": -2.37, "enterpriseToRevenue": 70.111, "enterpriseToEbitda": -1.701, "52WeekChange": -0.5009091, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 11.07, "targetHighPrice": 75.0, "targetLowPrice": 35.0, "targetMeanPrice": 49.66667, "targetMedianPrice": 39.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 431380000, "totalCashPerShare": 8.019, "ebitda": -94645000, "totalDebt": 1700000, "quickRatio": 45.272, "currentRatio": 47.433, "totalRevenue": 2296000, "debtToEquity": 0.381, "revenuePerShare": 0.087, "returnOnAssets": -0.16906, "returnOnEquity": -0.28616, "grossProfits": 2296000, "freeCashflow": -70180496, "operatingCashflow": -82775000, "revenueGrowth": -0.116, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -56.56007, "financialCurrency": "USD", "symbol": "UPB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1728653400000, "regularMarketChange": 0.09000015, "regularMarketDayRange": "10.6 - 11.335", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 408555, "fiftyTwoWeekLowChange": 5.93, "fiftyTwoWeekLowChangePercent": 1.1536965, "fiftyTwoWeekRange": "5.14 - 29.46", "fiftyTwoWeekHighChange": -18.39, "fiftyTwoWeekHighChangePercent": -0.6242362, "fiftyTwoWeekChangePercent": -50.090908, "earningsTimestamp": 1746529200, "earningsTimestampStart": 1754397000, "earningsTimestampEnd": 1754397000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.67, "epsForward": -2.37, "epsCurrentYear": -2.56845, "priceEpsCurrentYear": -4.3099923, "fiftyDayAverageChange": 1.2598, "fiftyDayAverageChangePercent": 0.12841736, "twoHundredDayAverageChange": -2.3905907, "twoHundredDayAverageChangePercent": -0.17759924, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "shortName": "Upstream Bio, Inc.", "corporateActions": [], "regularMarketTime": 1751396700, "exchange": "NMS", "messageBoardId": "finmb_1773603947", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Upstream Bio, Inc.", "regularMarketChangePercent": 0.81967354, "regularMarketPrice": 11.07, "marketState": "REGULAR", "displayName": "Upstream Bio", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]